Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

DAWNDAWN
Showing 7 of 12 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in DAY ONE BIOPHARMACEUTICALS I

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of DAWN (DAY ONE BIOPHARMACEUTICALS I), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$373,195

Total Shares Change

-29,455

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$21.45
0
2026-Q1
Increased
2.6M
+76.2%
$56.3M0.1%$10.03
45
2025-Q4
Increased
1.5M
+7.7%
$13.9M0.0%$9.18
30
2025-Q3
New
1.4M
-
$9.8M0.0%$6.99
38
2025-Q2
Exited
0
-100.0%
$00.0%$6.47
0
2025-Q1
Increased
133,641
+353.7%
$1.1M0.0%$8.07
41
2024-Q4
New
29,455
-
$373,1950.0%$12.58
33

Other major holders of DAWN: FMR LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used